Browsing: SUSTAIN 11

All

Once-Weekly Semaglutide Versus Thrice-Daily Insulin Aspart in Type 2 Diabetes

By FWANovember 29, 20240

In patients with type 2 diabetes treated with metformin and basal insulin, once-weekly semaglutide significantly improved glycaemic control (HbA1c reduction)…

Subscribe now

Welcome to Hormone Insight. Our mission is to support clinical decision-making with accessible, evidence-based insights from recent studies and trials.

CONTACT INFO

Privacy Policy
Disclaimer

Browsing: SUSTAIN 11

Once-Weekly Semaglutide Versus Thrice-Daily Insulin Aspart in Type 2 Diabetes

Does Oral Semaglutide Reduce Energy Intake and Improve Appetite Control in Adults With Obesity?

Once-Weekly Semaglutide Shows Promise in Improving Glycaemic Control and Weight Loss for Type 2 Diabetes Patients, Study Finds

Study Finds Semaglutide Reduces Cardiovascular Risk in Type 2 Diabetes Patients, but Raises Retinopathy Concerns

Study Shows Once-Weekly Semaglutide Effectively Lowers Blood Sugar and Aids Weight Loss in Type 2 Diabetes Patients

Subscribe now

CATEGORIES

CONTACT INFO